Literature DB >> 8408908

Treatment of facial telangiectasia with sclerotherapy, laser surgery, and/or electrodesiccation: a review.

M P Goldman, R A Weiss, H J Brody, W P Coleman, R E Fitzpatrick.   

Abstract

BACKGROUND: Facial telangiectasia is extremely common in patients with fair complexion. Electrosurgery has been the primary form of treatment in the past.
OBJECTIVES: The authors retrospectively evaluated over 300 patients treated with sclerotherapy for facial telangiectasias.
METHODS: Retrospective analysis of over 300 patients with facial telangiectasia treated with sclerotherapy and 55 facial spider telangiectasias treated with laser.
RESULTS: Sclerotherapy utilizing hypertonic saline, Sclerodex, polidocanol, and sodium tetradecyl sulfate resulted in-between 50 and 100% resolution of facial telangiectasia with minimal complications.
CONCLUSION: The treatment of facial telangiectasia should include sclerotherapy and laser treatment modalities, which effect a higher rate of clearance with less adverse sequela.

Entities:  

Mesh:

Year:  1993        PMID: 8408908     DOI: 10.1111/j.1524-4725.1993.tb00976.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  6 in total

1.  The Effect of 0.5% Sodium Tetradecyl Sulfate on a Venous Lake Lesion.

Authors:  Suck Joon Jung; Young Ju Seo; Eun Ju Park; Chul Woo Kim; Hee Jin Cho; Kwang Ho Kim; Kwang Joong Kim
Journal:  Ann Dermatol       Date:  2008-12-31       Impact factor: 1.444

Review 2.  Vascular anomalies of the head and neck: diagnosis and treatment.

Authors:  Frederic Bertino; Anna V Trofimova; Shenise N Gilyard; C Matthew Hawkins
Journal:  Pediatr Radiol       Date:  2021-04-16

3.  Combination of Specific Vascular Lasers and Vascular Intense Pulsed Light Improves Facial Telangiectasias and Redness.

Authors:  Luigi Bennardo; Cataldo Patruno; Elena Zappia; Federica Tamburi; Mario Sannino; Francesca Negosanti; Steven Paul Nisticò; Giovanni Cannarozzo
Journal:  Medicina (Kaunas)       Date:  2022-05-11       Impact factor: 2.948

4.  Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.

Authors:  Holly Boyer; Patricia Fernandes; Chap Le; Bevan Yueh
Journal:  Int Forum Allergy Rhinol       Date:  2015-02-02       Impact factor: 3.858

5.  Using the ultra-long pulse width pulsed dye laser and elliptical spot to treat resistant nasal telangiectasia.

Authors:  Vishal Madan; Janice Ferguson
Journal:  Lasers Med Sci       Date:  2009-07-28       Impact factor: 3.161

6.  Management of Facial Telangiectasias with Hand Cautery.

Authors:  Ioannis E Liapakis; Miriam Englander; Roven Sinani; Eleftherios I Paschalis
Journal:  World J Plast Surg       Date:  2015-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.